Using your own immune cells to treat advanced cancer
Treatments studied
Part of Cancer clinical trials.
This study tests a new treatment that takes immune cells from a small piece of your tumor, grows them in a lab, and then puts them back into your body to fight the cancer. It is for people with advanced lung, cervical, or breast cancer who have already tried standard treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old.
- You have advanced non-small cell lung cancer, cervical cancer, or breast cancer (only women).
- Standard treatments have stopped working, or you and your doctor agree no more standard options are available.
- You have at least one tumor that can be removed (at least the size of a sugar cube) to get immune cells, and another tumor that can be measured on scans.
- You are generally well enough to carry out daily activities (ECOG score 0-2) and are expected to live at least 3 more months.
- Your organs and bone marrow are working well enough, and you do not have serious infections or untreated brain metastases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment that uses your own immune cells, called TILs, to fight advanced solid tumors. The cells are taken from a biopsy of your tumor, multiplied in a lab, and then given back to you. It might help if you have tried other treatments without success, or if no standard treatment is available.
This trial tests whether immune cells taken from your own tumor (called tumor-infiltrating lymphocytes) can be grown in a lab and given back to you to fight the cancer. It is for people with advanced breast cancer who have exhausted standard treatment options.
This early-phase study tests a treatment made from your own tumor-fighting immune cells (TIL cells) for advanced solid cancers that have worsened or no longer respond to standard therapy. The main goal is to learn whether it is safe and whether it can shrink tumors for people who have limited options.
This trial tests an experimental cell therapy (HS-IT101) for people with advanced solid tumors that have not responded to standard treatments. It uses immune cells from your own tumor to fight cancer, and researchers want to see if it is safe and effective.
This trial tests an experimental cell therapy for people with advanced solid tumors that have not responded to standard treatments. The therapy uses immune cells from your own tumor, grown in the lab and given back to you, potentially to help your body fight the cancer.
This study tests a new treatment that uses your own immune cells, called TIL, to fight advanced solid tumors. It may be given alone or with another drug that helps the immune system attack cancer. The goal is to see if this treatment is safe and effective for people who have already tried other treatments.
Hear when a new Advanced Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.